Complete Filing Data
Century Therapeutics, Inc. reported Stockholders Equity of $158.94 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Century Therapeutics, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Income * | -$9.6M | -$126.6M | -$136.7M | -$130.9M | -$95.8M | -$53.6M |
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | $63.0K | -$32.0K | -$26.0K | -$32.0K | -$8.0K | |
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax | -$294.0K | $153.0K | $2.6M | -$1.8M | -$615.0K | $8.0K |
| Operating Income Loss | -$17.3M | -$138.1M | -$146.5M | -$133.8M | -$94.9M | -$53.9M |
| Operating Expenses | $126.4M | $144.7M | $148.8M | $139.0M | $94.9M | $53.9M |
| General And Administrative Expense | $24.0M | $33.2M | $34.7M | $31.9M | $19.2M | $9.5M |
| Comprehensive Income Net Of Tax | -$9.9M | -$126.4M | -$134.1M | -$132.7M | -$96.5M | -$53.6M |
| Other Nonoperating Income Expense | $275.0K | $354.0K | -$383.0K | $3.0M | -$898.0K | $323.0K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$9.6M | -$124.8M | -$134.8M | -$130.8M | -$95.8M | -$53.6M |
| Research And Development Expense Excluding Acquired In Process Cost | $95.7M | $107.2M | $92.7M | $97.2M | $75.6M | |
| Revenue From Contract With Customer Excluding Assessed Tax | $109.2M | $6.6M | $2.2M | $5.2M | ||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax | -$294.0K | $153.0K | $2.6M | -$1.8M | ||
| Income Tax Expense Benefit | -$68.0K | $1.8M | $1.9M | $91.0K | $43.0K | |
| Nonoperating Income Expense | $7.6M | $13.4M | $11.8M | $3.0M | ||
| Deferred Revenue Current | $109.2M | $4.4M | $7.2M | |||
| Deferred Revenue Noncurrent | $111.4M | $110.8M | ||||
| Other Nonoperating Income | $12.7M | $4.4M | $377.0K | $704.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$34.4M | -$32.5M | $76.6M | -$31.2M | -$31.2M | -$28.1M | -$32.7M | -$33.3M | -$31.3M | -$30.7M | -$31.0M | -$37.5M | -$26.0M | -$23.3M | -$18.3M | -$13.1M | -$15.3M | -$9.7M |
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | -$8.0K | $34.0K | $2.0K | -$2.0K | $9.0K | -$9.0K | -$5.0K | -$12.0K | -$6.0K | -$27.0K | -$9.0K | $4.0K | -$2.0K | |||||
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax | -$19.0K | -$222.0K | -$19.0K | $1.1M | -$102.0K | -$351.0K | -$95.0K | $59.0K | $1.2M | -$165.0K | -$780.0K | -$2.0M | -$33.0K | $32.0K | -$27.0K | -$79.0K | $97.0K | |
| Operating Income Loss | -$36.1M | -$34.7M | $74.2M | -$34.8M | -$34.8M | -$31.3M | -$35.6M | -$35.1M | -$32.1M | -$31.7M | -$31.4M | -$37.4M | -$25.8M | -$23.0M | -$18.1M | -$13.1M | -$15.5M | |
| Operating Expenses | $36.1M | $34.7M | $35.0M | $35.6M | $35.5M | $32.2M | $35.8M | $35.2M | $33.8M | $34.0M | $32.7M | $38.5M | $25.8M | $23.0M | $18.1M | $13.1M | $15.5M | |
| General And Administrative Expense | $6.8M | $7.8M | $8.4M | $8.4M | $8.3M | $8.7M | $9.0M | $8.2M | $8.9M | $8.1M | $8.3M | $7.3M | $6.3M | $4.1M | $2.7M | $2.3M | $2.3M | |
| Comprehensive Income Net Of Tax | -$34.4M | -$32.8M | $76.5M | -$30.2M | -$31.3M | -$28.4M | -$32.8M | -$33.2M | -$30.1M | -$30.9M | -$31.8M | -$39.5M | -$26.1M | -$23.3M | -$18.4M | -$13.2M | -$15.2M | |
| Other Nonoperating Income Expense | $97.0K | $113.0K | -$38.0K | $250.0K | -$12.0K | $11.0K | $12.0K | -$186.0K | -$194.0K | -$24.0K | $5.0K | -$61.0K | -$182.0K | -$252.0K | -$286.0K | $120.0K | $215.0K | |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$34.4M | -$32.5M | $76.6M | -$31.2M | -$31.2M | -$28.1M | -$32.1M | -$32.3M | -$30.1M | -$30.7M | -$31.0M | -$37.5M | -$26.0M | -$23.3M | -$18.3M | |||
| Research And Development Expense Excluding Acquired In Process Cost | $22.5M | $26.9M | $26.6M | $27.2M | $27.2M | $23.4M | $22.8M | $22.7M | $24.9M | $25.9M | $24.5M | $21.2M | $19.5M | $18.9M | $15.4M | |||
| Revenue From Contract With Customer Excluding Assessed Tax | $109.2M | $791.0K | $771.0K | $855.0K | $148.0K | $99.0K | $1.7M | $2.2M | $1.4M | $1.1M | ||||||||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax | -$19.0K | -$222.0K | -$19.0K | $1.1M | -$102.0K | -$351.0K | -$95.0K | $59.0K | $1.2M | -$165.0K | -$780.0K | -$2.0M | ||||||
| Income Tax Expense Benefit | -$8.0K | $22.0K | $1.0K | $592.0K | $950.0K | $1.2M | $25.0K | $18.0K | $16.0K | |||||||||
| Nonoperating Income Expense | $1.7M | $2.1M | $2.4M | $3.6M | $3.6M | $3.2M | $3.5M | $2.7M | $2.0M | $1.0M | $381.0K | |||||||
| Deferred Revenue Current | $3.6M | $4.4M | $4.6M | $3.9M | $6.9M | $6.5M | $7.6M | $7.8M | $6.4M | |||||||||
| Deferred Revenue Noncurrent | $109.8M | $109.8M | $110.3M | $112.2M | $109.2M | $109.8M | $110.9M | $112.9M | $115.8M | |||||||||
| Other Nonoperating Income | $2.6M | $1.4M | $711.0K | $253.0K | $140.0K | $66.0K | $28.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity | $158.9M | $161.4M | $184.8M | $302.7M | $396.2M | -$106.4M | -$91.9M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $65.0M | $61.2M | $49.3M | $86.2M | $58.2M | $27.7M | $44.1M |
| Short Term Investments | $55.3M | $130.9M | $125.4M | $231.2M | $166.4M | $48.5M | |
| Retained Earnings Accumulated Deficit | -$791.9M | -$782.3M | -$655.8M | -$519.1M | -$388.2M | -$292.3M | |
| Restricted Cash Noncurrent | $2.4M | $2.8M | $2.0M | $2.0M | $1.7M | $517.0K | |
| Property Plant And Equipment Net | $50.0M | $62.1M | $71.7M | $82.8M | $58.0M | $15.4M | |
| Prepaid Expense And Other Assets Current | $3.7M | $4.8M | $4.3M | $4.0M | $4.8M | $2.3M | |
| Operating Lease Right Of Use Asset | $16.1M | $28.7M | $20.4M | $28.9M | $11.9M | $9.4M | |
| Operating Lease Liability Noncurrent | $40.2M | $49.0M | $46.7M | $38.7M | $14.6M | $11.7M | |
| Non Cash Operating Lease Expense | $1.9M | -$271.0K | -$1.2M | $1.6M | $834.0K | $352.0K | |
| Liabilities Current | $20.2M | $129.8M | $17.8M | $29.8M | $15.7M | $12.1M | |
| Liabilities And Stockholders Equity | $223.7M | $353.2M | $360.7M | $486.5M | $437.4M | $106.8M | |
| Liabilities | $64.8M | $191.9M | $175.9M | $183.8M | $41.1M | $33.4M | |
| Deposits Assets Noncurrent | $211.0K | $528.0K | $541.0K | $1.3M | $1.5M | $909.0K | |
| Common Stock Value | $9.0K | $9.0K | $6.0K | $6.0K | $5.0K | $1.0K | |
| Cash And Cash Equivalents At Carrying Value | $61.9M | $58.4M | $47.3M | $84.3M | $56.4M | $27.2M | |
| Assets Current | $120.8M | $194.1M | $177.0M | $319.7M | $228.2M | $78.8M | |
| Assets | $223.7M | $353.2M | $360.7M | $486.5M | $437.4M | $106.8M | |
| Additional Paid In Capital Common Stock | $950.8M | $943.4M | $840.4M | $824.3M | $785.0M | $217.8M | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | $30.0K | $324.0K | $108.0K | -$2.5M | -$650.0K | -$3.0K | |
| Accrued Expenses And Other Liabilities Current | $11.7M | $17.5M | $10.1M | $9.8M | $6.0M | $4.0M | |
| Accounts Payable Current | $4.8M | $3.1M | $2.7M | $5.5M | $7.6M | $8.1M | |
| Long Term Investments | $30.8M | $89.1M | $51.9M | $135.9M | $1.1M | ||
| Deposit Liability Current | $20.0K | $82.0K | $584.0K | $866.0K | $980.0K | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $3.8M | $11.9M | -$36.9M | $28.1M | $30.4M | ||
| Deposit Liability Noncurrent | $56.0K | $718.0K | $2.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $176.3M | $209.9M | $240.4M | $195.7M | $222.1M | $177.9M | $219.2M | $247.6M | $277.2M | $330.2M | $358.0M | $386.7M | $423.0M | $447.6M | -$91.6M | -$129.3M | -$116.4M | -$101.3M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $58.7M | $59.6M | $54.6M | $55.4M | $44.3M | $48.8M | $57.3M | $66.4M | $88.8M | $113.3M | $114.8M | $127.8M | $103.0M | $274.5M | $80.0M | $23.6M | $22.8M | ||
| Short Term Investments | $77.2M | $99.0M | $113.3M | $145.5M | $154.9M | $145.2M | $114.2M | $92.0M | $164.6M | $244.5M | $266.0M | $235.0M | $193.9M | $125.3M | |||||
| Retained Earnings Accumulated Deficit | -$772.7M | -$738.3M | -$705.8M | -$746.3M | -$715.0M | -$683.8M | -$616.4M | -$583.7M | -$550.4M | -$487.4M | -$456.7M | -$425.7M | -$360.0M | -$334.0M | |||||
| Restricted Cash Noncurrent | $2.3M | $2.7M | $2.8M | $2.8M | $2.8M | $2.0M | $2.0M | $2.0M | $2.0M | $2.0M | $2.0M | $1.7M | $1.7M | $2.2M | |||||
| Property Plant And Equipment Net | $53.7M | $56.6M | $59.5M | $65.3M | $69.4M | $69.0M | $82.0M | $83.8M | $85.8M | $77.9M | $70.0M | $64.7M | $48.6M | $34.5M | |||||
| Prepaid Expense And Other Assets Current | $5.0M | $4.3M | $4.5M | $7.9M | $7.1M | $7.8M | $4.2M | $4.9M | $4.5M | $5.4M | $4.6M | $3.7M | $4.7M | $4.6M | |||||
| Operating Lease Right Of Use Asset | $16.6M | $27.7M | $28.2M | $28.8M | $28.6M | $19.3M | $24.6M | $25.0M | $28.2M | $29.5M | $24.7M | $11.7M | $12.0M | $12.3M | |||||
| Operating Lease Liability Noncurrent | $41.2M | $46.6M | $47.8M | $50.8M | $52.7M | $44.3M | $45.5M | $40.8M | $41.2M | $36.6M | $30.4M | $14.4M | $14.8M | $14.8M | |||||
| Non Cash Operating Lease Expense | $474.0K | $1.5M | -$738.0K | $188.0K | $230.0K | ||||||||||||||
| Liabilities Current | $22.0M | $14.9M | $14.5M | $19.8M | $19.2M | $16.1M | $20.4M | $19.2M | $27.7M | $26.9M | $21.6M | $22.0M | $19.9M | $21.2M | |||||
| Liabilities And Stockholders Equity | $244.7M | $284.7M | $315.6M | $388.6M | $416.4M | $348.5M | $397.6M | $417.2M | $456.2M | $511.8M | $532.6M | $550.3M | $469.7M | $495.6M | |||||
| Liabilities | $68.4M | $74.8M | $75.2M | $192.9M | $194.3M | $170.6M | $178.3M | $169.6M | $179.1M | $181.5M | $174.6M | $163.6M | $46.7M | $48.0M | |||||
| Deposits Assets Noncurrent | $213.0K | $538.0K | $526.0K | $565.0K | $541.0K | $544.0K | $563.0K | $555.0K | $950.0K | $1.3M | $1.5M | $1.5M | $1.4M | $1.0M | |||||
| Common Stock Value | $9.0K | $9.0K | $9.0K | $9.0K | $8.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $5.0K | $5.0K | |||||
| Cash And Cash Equivalents At Carrying Value | $55.5M | $56.9M | $51.9M | $52.6M | $41.5M | $46.8M | $55.3M | $64.4M | $86.8M | $111.4M | $112.8M | $126.0M | $101.3M | $272.3M | |||||
| Assets Current | $137.7M | $160.2M | $169.6M | $206.0M | $203.5M | $199.8M | $173.7M | $161.3M | $255.9M | $361.6M | $383.8M | $365.3M | $300.4M | $402.6M | |||||
| Assets | $244.7M | $284.7M | $315.6M | $388.6M | $416.4M | $348.5M | $397.6M | $417.2M | $456.2M | $511.8M | $532.6M | $550.3M | $469.7M | $495.6M | |||||
| Additional Paid In Capital Common Stock | $949.0M | $948.1M | $945.9M | $941.2M | $937.4M | $862.0M | $836.9M | $832.4M | $828.8M | $821.2M | $818.0M | $815.0M | $783.0M | $781.6M | |||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $64.0K | $83.0K | $305.0K | $758.0K | -$309.0K | -$241.0K | -$1.3M | -$1.2M | -$1.3M | -$3.6M | -$3.4M | -$2.6M | -$63.0K | -$3.0K | |||||
| Accrued Expenses And Other Liabilities Current | $11.1M | $11.7M | $10.9M | $13.4M | $11.1M | $7.5M | $9.9M | $7.9M | $6.5M | $8.8M | $7.2M | $4.8M | $7.3M | $6.8M | |||||
| Accounts Payable Current | $2.6M | $3.2M | $3.6M | $2.6M | $3.4M | $3.4M | $5.9M | $3.6M | $3.5M | $5.7M | $4.0M | $9.9M | $11.6M | $13.4M | |||||
| Long Term Investments | $2.7M | $20.7M | $46.6M | $73.2M | $57.9M | $114.8M | $144.6M | $83.3M | $39.4M | $50.6M | $105.4M | $105.2M | $42.5M | ||||||
| Deposit Liability Current | $20.0K | $20.0K | $209.0K | $350.0K | $491.0K | $705.0K | $744.0K | $881.0K | $860.0K | $857.0K | $857.0K | $966.0K | $966.0K | $0.00 | |||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$6.6M | -$512.0K | $2.6M | $69.6M | |||||||||||||||
| Deposit Liability Noncurrent | $201.0K | $361.0K | $433.0K | $971.0K | $1.2M | $1.5M | $2.3M | $2.3M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Share Based Compensation | $6.8M | $12.7M | $14.6M | $10.7M | $4.7M | $876.0K |
| Proceeds From Sale Of Available For Sale Securities Debt | $159.5M | $176.8M | $283.9M | $271.5M | $76.7M | $41.7M |
| Payments To Acquire Available For Sale Securities Debt | $51.2M | $119.5M | $209.0M | $254.0M | $330.0M | $49.9M |
| Net Cash Provided By Used In Operating Activities | -$103.9M | -$110.1M | -$88.3M | $14.1M | -$89.0M | -$41.3M |
| Net Cash Provided By Used In Investing Activities | $107.5M | $47.5M | $61.1M | -$13.1M | -$298.3M | -$22.8M |
| Net Cash Provided By Used In Financing Activities | $173.0K | $74.6M | -$9.7M | $27.2M | $417.8M | $47.7M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$2.3M | -$543.0K | -$667.0K | -$1.0M | $3.2M | $203.0K |
| Increase Decrease In Operating Lease Liability | -$5.0M | -$3.4M | $13.8M | $5.3M | -$41.0K | $2.2M |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -$4.3M | $1.6M | -$730.0K | $4.0M | $1.5M | $2.3M |
| Increase Decrease In Accounts Payable | $1.6M | -$1.5M | -$2.4M | -$4.8M | -$1.8M | $2.1M |
| Payments To Acquire Property Plant And Equipment | $848.0K | $154.0K | $13.7M | $30.6M | $45.0M | $9.8M |
| Proceeds From Issuance Of Common Stock | $173.0K | $141.0K | $516.0K | $345.0K | $213.0K | |
| Increase Decrease In Deferred Revenue | -$109.2M | -$6.6M | -$2.2M | $118.0M | ||
| Increase Decrease In Escrow Deposit | -$220.0K | -$502.0K | -$784.0K | $1.5M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|
| Share Based Compensation | $2.4M | $3.2M | $3.8M | $2.4M | $95.0K |
| Proceeds From Sale Of Available For Sale Securities Debt | $43.3M | $47.2M | $79.2M | $63.1M | $7.7M |
| Payments To Acquire Available For Sale Securities Debt | $14.9M | $35.1M | $42.8M | $103.1M | $124.9M |
| Net Cash Provided By Used In Operating Activities | -$34.6M | -$30.2M | -$29.2M | $86.8M | -$22.2M |
| Net Cash Provided By Used In Investing Activities | $27.9M | $11.5M | $31.3M | -$44.0M | -$119.0M |
| Net Cash Provided By Used In Financing Activities | $120.0K | $18.2M | $448.0K | $26.9M | $193.5M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$289.0K | $3.4M | $160.0K | -$1.0M | -$173.0K |
| Increase Decrease In Operating Lease Liability | -$1.2M | -$2.2M | $3.8M | -$152.0K | $127.0K |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -$6.5M | -$3.3M | -$3.2M | -$1.2M | -$311.0K |
| Increase Decrease In Accounts Payable | $361.0K | $689.0K | -$3.0M | -$1.5M | -$4.9M |
| Payments To Acquire Property Plant And Equipment | $475.0K | $539.0K | $5.0M | $4.1M | $1.9M |
| Proceeds From Issuance Of Common Stock | $120.0K | $366.0K | $448.0K | $65.0K | $47.0K |
| Increase Decrease In Deferred Revenue | -$109.2M | -$855.0K | -$1.7M | $122.1M | |
| Increase Decrease In Escrow Deposit | -$220.0K | -$125.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 86.6M | 78.6M | 59.3M | 57.8M | 32.4M | 7.5M |
| Earnings Per Share Basic | $-0.14 | $-1.61 | $-2.30 | $-2.27 | $-2.96 | $-7.16 |
| Weighted Average Number Of Diluted Shares Outstanding | 86.6M | 78.6M | 59.3M | 32.4M | 32.4M | 7.5M |
| Earnings Per Share Diluted | $-0.14 | $-1.61 | $-2.30 | $-2.96 | $-2.96 | $-7.16 |
| Common Stock Shares Authorized | 300.0M | 300.0M | 300.0M | 300.0M | 125.2M | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 0.00 | |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Common Stock Shares Outstanding | 87.5M | 85.8M | 60.3M | 55.0M | 58.5M | 7.5M |
| Common Stock Shares Issued | 87.5M | 85.8M | 60.3M | 58.5M | 58.5M | 7.5M |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 86.5M | 86.2M | 86.0M | 84.7M | 82.1M | 62.3M | 59.4M | 59.3M | 58.6M | 58.0M | 57.7M | 57.1M | 54.5M | 12.0M | 7.7M | 7.5M | 7.5M | ||
| Earnings Per Share Basic | $-0.40 | $-0.38 | $0.89 | $-0.37 | $-0.38 | $-0.45 | $-0.55 | $-0.56 | $-0.53 | $-0.53 | $-0.54 | $-0.66 | $-0.48 | $-1.93 | $-2.39 | $-1.75 | $-2.05 | ||
| Weighted Average Number Of Diluted Shares Outstanding | 86.5M | 86.2M | 86.1M | 84.7M | 82.1M | 62.3M | 59.4M | 59.3M | 58.6M | 58.0M | 57.7M | 57.1M | 54.5M | 12.0M | 7.7M | 7.5M | |||
| Earnings Per Share Diluted | $-0.40 | $-0.38 | $0.89 | $-0.37 | $-0.38 | $-0.45 | $-0.55 | $-0.56 | $-0.53 | $-0.53 | $-0.54 | $-0.66 | $-0.48 | $-1.93 | $-2.39 | $-1.75 | |||
| Common Stock Shares Authorized | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 125.2M | 125.2M | 125.2M | 300.0M | 300.0M | 300.0M | 300.0M | |||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | |||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||
| Common Stock Shares Outstanding | 86.5M | 86.3M | 86.1M | 84.6M | 84.6M | 60.3M | 59.5M | 59.3M | 59.1M | 58.2M | 57.6M | 57.6M | 54.6M | 54.4M | |||||
| Common Stock Shares Issued | 86.5M | 86.3M | 86.1M | 84.8M | 84.6M | 64.8M | 59.5M | 59.3M | 59.1M | 58.2M | 57.9M | 57.6M | 54.6M | 54.4M | |||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $6.8M | $12.7M | $14.6M | $10.7M | $4.7M | $876.0K |
| Stock Issued During Period Value Vesting Of Early Exercise Stock Options | $82.0K | $558.0K | $943.0K | $1.4M | $426.0K | |
| Depreciation | $13.1M | $13.3M | $13.0M | $8.4M | $3.7M | $1.4M |
| Stock Issued During Period Value Stock Options Exercised | $173.0K | $773.0K | $943.0K | $345.0K | $213.0K | |
| Amortization Of Financing Costs | $94.0K | $299.0K | $306.0K | $92.0K | ||
| Interest Income Other | $7.3M | $13.0M | $12.7M | |||
| Interest Paid Net | $586.0K | $1.1M | $969.0K | $207.0K | ||
| Capital Expenditures Incurred But Not Yet Paid | $352.0K | $2.7M | $1.4M | $4.5M | ||
| Stock Issued During Period Value New Issues | $17.8M | $221.4M | ||||
| Escrow Deposits Current | $220.0K | $502.0K | $783.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $891.0K | $2.2M | $2.4M | $3.3M | $3.5M | $3.2M | $4.0M | $3.3M | $3.8M | $2.8M | $2.8M | $2.4M | $1.2M | $1.7M | $95.0K | $144.0K | $137.0K | $221.0K |
| Stock Issued During Period Value Vesting Of Early Exercise Stock Options | $84.0K | $141.0K | $141.0K | $142.0K | $199.0K | $209.0K | $269.0K | $248.0K | $250.0K | $673.0K | $14.0K | $46.0K | $123.0K | |||||
| Depreciation | $3.1M | $3.2M | $3.2M | $3.3M | $3.5M | $3.2M | $3.4M | $3.2M | $2.9M | $2.8M | $1.7M | $1.2M | $1.0M | $935.0K | $718.0K | $410.0K | $282.0K | |
| Stock Issued During Period Value Stock Options Exercised | $120.0K | $282.0K | $103.0K | $366.0K | $299.0K | $125.0K | $448.0K | $138.0K | $47.0K | $65.0K | $9.0K | $74.0K | $47.0K | |||||
| Amortization Of Financing Costs | $56.0K | $77.0K | $76.0K | $76.0K | $77.0K | $76.0K | $75.0K | $14.0K | ||||||||||
| Interest Income Other | $1.6M | $2.0M | $2.4M | $3.3M | $3.6M | $3.2M | $3.5M | $3.1M | $2.6M | $1.4M | $706.0K | |||||||
| Interest Paid Net | $345.0K | $238.0K | $239.0K | |||||||||||||||
| Capital Expenditures Incurred But Not Yet Paid | $975.0K | $3.8M | $1.6M | |||||||||||||||
| Stock Issued During Period Value New Issues | $17.8M | $26.8M | $217.0K | $221.2M | ||||||||||||||
| Escrow Deposits Current | $346.0K | $471.0K | $502.0K | $502.0K | $419.0K |
Most recent annual filing with the SEC: March 12, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.